Tag: PTSD

August 4, 2020

Medical Psilocybin and the Emerging “Functional” Mushrooms Market

The remedial potential of psilocybin has helped open the doors to a new world of potential treatments and psychedelic therapies. 
April 26, 2018

Canntab Therapeutics Files 11 Patent Applications Related to Pharmaceutical Cannabis

Canntab Therapeutics Limited (CSE: PILL) (formerly Telferscot Resources Inc.) ("Canntab" or the "Company") is pleased to announce that it continues...
April 20, 2018

GreenTec Holdings Announces Commencement of Cultivation and Rebranding at GrenEx Pharms and Provides Shareholder Updates

GreenTec Holdings Ltd. (“GTEC”) is pleased to announce the commencement of cultivation and rebranding of its wholly owned Licensed Producer...
April 11, 2018

Helius Medical Begins Listing on the NASDAQ

A company getting approval to list to the NASDAQ means a more international reach for Canadian companies listing on the...
April 9, 2018

CBD​ ​is​ ​Improving​ ​Health​ ​and​ ​Driving​ ​the​ ​Cannabis​ ​Industry

CBD​ ​is​ ​improving​ ​health​ ​and​ driving​ ​the​ ​cannabis​ ​industry. Know more about its health benefits and opportunities for CBD-based companies.
March 22, 2018

Tonix Pharmaceuticals Expands Intellectual Property Portfolio for TNX-102 SL

Tonix Pharmaceuticals (Nasdaq:TNXP) a clinical-stage biopharmaceutical company focused on developing pharmaceutical products to treat serious neuropsychiatric conditions and biological products...
March 5, 2018

Neil Closner, MedReleaf’s CEO Talks Potential for DNA Cannabis Test

Neil Closner, CEO of MedReleaf spoke with INN about the company’s medical focus and their DNA-test for patients looking for...